“Hey Shareholders, Don’t Miss Out! Levi and Korsinsky Have a Reminder for You About the Regeneron Pharmaceuticals Inc. Lawsuit Deadline on March 10, 2025”

Facing a Loss on Your Regeneron Pharmaceuticals Investment? Don’t Worry, You’re Not Alone Hey there, fellow investor! If you’re feeling a bit down about your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment taking a hit, you’re definitely not alone. It happens to the best of us, but the good news is that there may be a potential…

Read More

Accelerate Your Product Development Process with Tempo Automation: A Proven Solution for Faster Time-to-Market

Tempo Automation Helps Blur Product Development Bring Products to Market Faster Tempo accelerates Blur’s medical device prototyping SAN FRANCISCO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Tempo Automation Holdings, Inc. (Nasdaq: TMPO) (“Tempo Automation” or “Tempo”) announced today that Blur Product Development (“Blur”), a leading medical device design and development partner, has elected to leverage Tempo’s…

Read More

Breaking News: Brodsky & Smith Launches Investigations on BTRS Holdings Inc., SeaSpine Holdings Corporation, and Talos Energy Inc. – What Investors Need to Know

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations BTRS Holdings Inc. (Nasdaq – BTRS) BALA CYNWYD, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) – Brodsky & Smith is reminding investors of the ongoing investigations regarding BTRS Holdings Inc. If you own shares in BTRS Holdings Inc. and would like to discuss the investigation…

Read More